Scholar Rock Holding (SRRK) Treasury Shares (2017 - 2026)
Scholar Rock Holding's quarterly Treasury Shares came in at $3.8 million in Q1 2026, up 3.59% year-on-year from $3.7 million in Q1 2025, and up 16.77% quarter-over-quarter from $3.3 million in Q4 2025.
Scholar Rock Holding has reported Treasury Shares for 10 years, with the latest figure at $3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 3.59% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 3.59% YoY), and the FY2025 full-year result was $3.3 million, down 5.81% from the prior year.
- Treasury Shares for Q1 2026 stood at $3.8 million, up from $3.3 million in the prior quarter.
- The five-year high for Treasury Shares was $3.8 million in Q1 2026, with the low at $1.0 million in Q1 2022.
- Average Treasury Shares over 5 years is $2.7 million, with a median of $3.0 million recorded in 2024.
- Year-over-year, Treasury Shares soared 19231.28% in 2022 and slipped 5.81% in 2025.
- Tracing SRRK's Treasury Shares over 5 years: stood at $1.7 million in 2022, then increased by 25.31% to $2.1 million in 2023, then surged by 66.86% to $3.5 million in 2024, then decreased by 5.81% to $3.3 million in 2025, then advanced by 16.77% to $3.8 million in 2026.
- The last three Treasury Shares figures came in at $3.8 million (Q1 2026), $3.3 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.83 Mn |
| Mar 31, 2026 | 3.83 Mn |
| Dec 31, 2025 | 3.28 Mn |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 2.98 Mn |
| Jun 30, 2024 | 2.98 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 1.67 Mn |
| Dec 31, 2022 | 1.67 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 314,901.00 |
| Dec 31, 2021 | 314,901.00 |
| Sep 30, 2021 | 254,156.00 |
| Sep 30, 2021 | 254,156.00 |
| Jun 30, 2021 | 9,387.00 |
| Jun 30, 2021 | 9,387.00 |
| Mar 31, 2021 | 247,067.00 |
| Mar 31, 2021 | 247,067.00 |
| Dec 31, 2020 | 57,969.00 |
| Dec 31, 2020 | 57,969.00 |
| Sep 30, 2020 | 86,116.00 |
| Sep 30, 2020 | 86,116.00 |
| Jun 30, 2020 | 126,646.00 |
| Jun 30, 2020 | 126,646.00 |
| Mar 31, 2020 | 227,064.00 |
| Mar 31, 2020 | 227,064.00 |
| Dec 31, 2019 | 302,360.00 |
| Dec 31, 2019 | 302,360.00 |
| Sep 30, 2019 | 388,902.00 |
| Sep 30, 2019 | 388,902.00 |
| Jun 30, 2019 | 480,663.00 |
| Jun 30, 2019 | 480,663.00 |
| Mar 31, 2019 | 571,437.00 |
| Mar 31, 2019 | 571,437.00 |
| Dec 31, 2018 | 664,174.00 |
| Dec 31, 2018 | 664,174.00 |
| Dec 31, 2017 | 1.22 Mn |
| Dec 31, 2017 | 1.22 Mn |